Research around β2-glycoprotein I: A major target for antiphospholipid antibodies

Tatsuya Atsumi, Olga Amengual, Shinsuke Yasuda, Eiji Matsuura, Takao Koike

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

β2-Glycoprotein I (β2GPI), a phospholipid-binding protein, is one of the major target antigens for antiphospholipid antibodies (aPL) found in patients with antiphospholipid syndrome (APS). Thrombophilic disorders in APS patients are strongly associated with aPL, and their pathogenic properties depend on the presence of β2GPI. Procoagulant cell stimulation by aPL, via β2GPI, is one of the most plausible mechanisms of thrombosis in APS, and p38 mitogen activated protein kinase (MAPK) pathway plays a crucial role in such activation. β2GPI is proteolytically cleaved in domain V by activated factor X or plasmin, leading to the generation of the nicked form of β2GPI. Recently, increasing attention is focused on the role of nicked-β2GPI as a regulator of extrinsic fibrinolysis pathway.

Original languageEnglish
Pages (from-to)377-381
Number of pages5
JournalAutoimmunity
Volume38
Issue number5
DOIs
Publication statusPublished - Aug 2005

Fingerprint

Antiphospholipid Antibodies
Glycoproteins
Antiphospholipid Syndrome
Research
Factor Xa
Fibrinolysin
p38 Mitogen-Activated Protein Kinases
Fibrinolysis
Phospholipids
Carrier Proteins
Thrombosis
Antigens

Keywords

  • APS
  • Fibrinolysis
  • Nicked-β2GPI
  • Thrombosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Research around β2-glycoprotein I : A major target for antiphospholipid antibodies. / Atsumi, Tatsuya; Amengual, Olga; Yasuda, Shinsuke; Matsuura, Eiji; Koike, Takao.

In: Autoimmunity, Vol. 38, No. 5, 08.2005, p. 377-381.

Research output: Contribution to journalArticle

Atsumi, Tatsuya ; Amengual, Olga ; Yasuda, Shinsuke ; Matsuura, Eiji ; Koike, Takao. / Research around β2-glycoprotein I : A major target for antiphospholipid antibodies. In: Autoimmunity. 2005 ; Vol. 38, No. 5. pp. 377-381.
@article{6852b6e0db5d4a3b8964e63f22928b69,
title = "Research around β2-glycoprotein I: A major target for antiphospholipid antibodies",
abstract = "β2-Glycoprotein I (β2GPI), a phospholipid-binding protein, is one of the major target antigens for antiphospholipid antibodies (aPL) found in patients with antiphospholipid syndrome (APS). Thrombophilic disorders in APS patients are strongly associated with aPL, and their pathogenic properties depend on the presence of β2GPI. Procoagulant cell stimulation by aPL, via β2GPI, is one of the most plausible mechanisms of thrombosis in APS, and p38 mitogen activated protein kinase (MAPK) pathway plays a crucial role in such activation. β2GPI is proteolytically cleaved in domain V by activated factor X or plasmin, leading to the generation of the nicked form of β2GPI. Recently, increasing attention is focused on the role of nicked-β2GPI as a regulator of extrinsic fibrinolysis pathway.",
keywords = "APS, Fibrinolysis, Nicked-β2GPI, Thrombosis",
author = "Tatsuya Atsumi and Olga Amengual and Shinsuke Yasuda and Eiji Matsuura and Takao Koike",
year = "2005",
month = "8",
doi = "10.1080/08916930500124312",
language = "English",
volume = "38",
pages = "377--381",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Research around β2-glycoprotein I

T2 - A major target for antiphospholipid antibodies

AU - Atsumi, Tatsuya

AU - Amengual, Olga

AU - Yasuda, Shinsuke

AU - Matsuura, Eiji

AU - Koike, Takao

PY - 2005/8

Y1 - 2005/8

N2 - β2-Glycoprotein I (β2GPI), a phospholipid-binding protein, is one of the major target antigens for antiphospholipid antibodies (aPL) found in patients with antiphospholipid syndrome (APS). Thrombophilic disorders in APS patients are strongly associated with aPL, and their pathogenic properties depend on the presence of β2GPI. Procoagulant cell stimulation by aPL, via β2GPI, is one of the most plausible mechanisms of thrombosis in APS, and p38 mitogen activated protein kinase (MAPK) pathway plays a crucial role in such activation. β2GPI is proteolytically cleaved in domain V by activated factor X or plasmin, leading to the generation of the nicked form of β2GPI. Recently, increasing attention is focused on the role of nicked-β2GPI as a regulator of extrinsic fibrinolysis pathway.

AB - β2-Glycoprotein I (β2GPI), a phospholipid-binding protein, is one of the major target antigens for antiphospholipid antibodies (aPL) found in patients with antiphospholipid syndrome (APS). Thrombophilic disorders in APS patients are strongly associated with aPL, and their pathogenic properties depend on the presence of β2GPI. Procoagulant cell stimulation by aPL, via β2GPI, is one of the most plausible mechanisms of thrombosis in APS, and p38 mitogen activated protein kinase (MAPK) pathway plays a crucial role in such activation. β2GPI is proteolytically cleaved in domain V by activated factor X or plasmin, leading to the generation of the nicked form of β2GPI. Recently, increasing attention is focused on the role of nicked-β2GPI as a regulator of extrinsic fibrinolysis pathway.

KW - APS

KW - Fibrinolysis

KW - Nicked-β2GPI

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=25444450310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444450310&partnerID=8YFLogxK

U2 - 10.1080/08916930500124312

DO - 10.1080/08916930500124312

M3 - Article

C2 - 16227153

AN - SCOPUS:25444450310

VL - 38

SP - 377

EP - 381

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 5

ER -